AbbVie | ABBV - Cash And Equivalent

Abbvie reported $11.83B in Cash and Equivalent for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cash And Equivalent Change
ALKERMES ALKS:US USD 740.08M 476.12M
Amgen AMGN:US USD 9.3B 197M
AstraZeneca AZN:LN USD 6.17B 1.71B
Astrazeneca AZN:US USD 6.17B 1.71B
Biogen BIIB:US USD 3.42B 256.3M
Biomarin Pharmaceutical BMRN:US USD 724.53M 36.98M
Bristol Myers Squibb BMY:US USD 9.12B 1.39B
Coherus Biosciences CHRS:US USD 63.55M 223.26M
Eisai 4523:JP JPY 268B 3.48B
Endo International Ordinary Shares ENDP:US USD 1.05B 137.68M
Gilead Sciences GILD:US USD 7.63B 2.93B
GlaxoSmithKline GSK:LN GBP 3.72B 117M
Horizon Pharma HZNP:US USD 2.35B 222.31M
Infinity Pharmaceuticals INFI:US USD 47.18M 1.34M
Intercept Pharmaceuticals ICPT:US USD 50.52M 62.68M
Jazz Pharmaceuticals JAZZ:US USD 517.46M 34.79M
Medtronic MDT:US USD 4.52B 307M
Neurocrine Biosciences NBIX:US USD 262.9M 50.7M
Novartis NOVN:VX USD 7.52B 1.21B
Pacira Pharmaceuticals PCRX:US USD 104.14M 5.28M
Perrigo Ordinary Shares PRGO:US USD 600.7M 132M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Revance Therapeutics RVNC:US USD 108.96M 4.47M
Roche Holding ROG:VX 4.99B 676M
Teva Pharmaceutical Industries TEVA:US USD 2.8B 576M
Ultragenyx Pharmaceutical RARE:US USD 132.94M 258.71M
United Therapeutics UTHR:US USD 961.2M 5.6M
Vertex Pharmaceuticals VRTX:US USD 10.78B 1.61B
Zoetis ZTS:US USD 3.58B 1.07B